Health
Looking beyond COVID-19’s spike protein for the next wave of vaccines – FierceBiotech
Most ongoing vaccine development efforts against the novel coronavirus focus on the spike protein on the surface of SARS-CoV-2. But a team led by immuno-oncology specialist TScan Therapeutics found that memory CD8+ T cells from recovered patients mainly targe…
Most ongoing vaccine development efforts against the novel coronavirus use the spike protein on the surface of SARS-CoV-2 in the hopes of inducing neutralizing antibodies that can directly block the virus from infecting healthy cells. But there could be one major caveat to that approach: The antibody response to the virus, mediated by B cells of the immune system, appears to wane quickly.
Thats why a research team led by immuno-oncology biotech TScan Therapeutics turned to another key component…
-
Noosa News24 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News13 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News23 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
General20 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76